Gabapentin Tablet
Product Images NDC 71335-2038

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Equation (Gabapentin Equation)

Gabapentin Equation (Gabapentin Equation)
This appears to be a medical calculation related to estimating the glomerular filtration rate (GFR) using the Cockcroft-Gault equation, which takes into account a person's serum creatinine level, age, weight, and sex. The equation is used to assess kidney function and determine appropriate dosages of medication for patients with kidney disease. The text refers to the calculation using serum creatinine level and age (represented by CLCr and 72, respectively), and indicates a gender-specific adjustment for female patients (0.85 factor).*
FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
This is a clinical trial result indicating the mean pain score for a 4-week dose titration period and a subsequent 4-week fixed dose period, where placebo and Gabapentin at a dosage of 3600 mg/day were tested. The only available data in the text is the number 10, which is likely referring to the mean pain score. No other information can be extracted from this text.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Gabapentin-fig2 (Gabapentin Fig2)
The text provided is a table that shows the Mean Pain Score of different groups of patients in a clinical trial. It includes four columns: the first one represents the baseline, the second indicates the number of weeks of the trial, and the third and fourth columns present the mean pain score for the placebo group and the two groups that received different doses of Gabapentin (1800 and 2400 mg/day), respectively.*
FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

Gabapentin-fig3 (Gabapentin Fig3)
The text provides a figure showing the proportion of responders in controlled PHN studies. The figure displays percentages ranging from 0% to 100% with intervals of 10%. The legend also includes the labels for the different studies and the corresponding drugs. However, no other relevant information is available, and it is not clear what the values represent without additional context.*
FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

FDA Label Image

Gabapentin-structure (Gabapentin Structure)

FDA Label Image

Label (Lbl713352038)

Label (Lbl713352038)
This is information on a medication named "Neurontin 800mg (CV)" in tablet form, packaged by Bryant Ranck under the name "Prepack". It can be compared to a similar medication manufactured by Alkem Laboratories Limited. The package contains 90 tablets with an expiration date of MM/YY, and the NDC number is 7133520381. The medication should be stored at room temperature. The text also includes a warning to keep all drugs out of reach of children. The last string of characters may be a barcode or batch number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.